天域生物科技股份有限公司关于公司提起诉讼的公告

Core Viewpoint - The company, Tianyu Biotechnology Co., Ltd., has initiated a lawsuit to exercise its shareholder rights and obtain financial information from the target company, Qinghai Juzhiyuan New Materials Co., Ltd., in order to accurately calculate the cash compensation owed by Liu Bingsheng for unmet performance commitments [2][12]. Group 1: Background of the Lawsuit - On March 28, 2022, the company signed a strategic investment agreement with Qinghai Juzhiyuan and Liu Bingsheng, investing 210 million RMB for a 35% stake, with a performance commitment of 900 million RMB in net profit over three years [3][11]. - The agreement includes provisions for cash compensation if the performance commitments are not met, allowing the company to either repurchase shares or receive cash compensation for any shortfall [3][11]. Group 2: Progress of Compensation Recovery - In August 2023, the company filed for arbitration due to Qinghai Juzhiyuan's 2022 net profit loss and Liu Bingsheng's failure to fulfill compensation obligations, resulting in an arbitration ruling in June 2025 that ordered Liu Bingsheng to pay 43.2953 million RMB in cash compensation [4][5]. - The company has applied for enforcement of this ruling in July 2025, but the execution status remains uncertain as it is still under court review [4][5]. Group 3: Current Lawsuit Details - The lawsuit was filed in July 2025 at the Qinghai Delingha People's Court, with the company requesting access to financial reports and accounting records from 2022 to 2024 to verify the performance commitments [9][10]. - The company asserts its right to access these documents as a shareholder, emphasizing that the refusal to provide such information has severely harmed its legal rights [11]. Group 4: Impact on Financials - The impact of the lawsuit on the company's current or future profits remains uncertain as the case has not yet been heard in court [2][12]. - The company is committed to monitoring the lawsuit closely and will disclose updates as necessary to protect the interests of itself and its shareholders [12].